Joshua Riggs
President, CEO & DirectorMr. Joshua Riggs, also known as Josh, serves as Director of Insight Molecular Diagnostics Inc. (formerly known as OncoCyte Corporation) since February 28, 2023, serves as its Chief Executive Officer & President since February 24, 2023 to February 2023. He served as Interim Chief Executive Officer of Insight Molecular Diagnostics Inc. (formerly known as OncoCyte Corporation) since December 02, 2022. He joined Insight Molecular Diagnostics Inc. (formerly known as OncoCyte Corporation) in August 2020. Mr. Riggs was Oncocyte's General Manager of Transplant from July 2022 to December 2022 and was its Senior Director Business Development from August 2020 until September 2022 and is a seasoned business development strategist with significant past work during early and growth-stage molecular diagnostics companies. From January 2015 to August 2020, Mr. Riggs was the Founder and Principal of Intelliger Consulting. From January 2016 to July 2020, he was a Principal at Bethesda Group, LLC. Mr. Riggs received a BA in Interdisciplinary Studies from Adelphi University and an MBA from the University of Mississippi.
公司職務
- 公司名稱Insight Molecular Diagnostics Inc.股票代碼IMDX職務President, CEO & Director共事同僚
- AAAndrew ArnoIndependent Chairman
- ASAndrea Susan JamesChief Financial Officer
- JLJames LiuVP of Accounting, Treasurer, Controller & Principal Accounting Officer
- YCYuh-Min ChiangChief Technology Officer
- ESEkkehard SchutzChief Science Officer
- AJAndrew J. LastIndependent Director
- LELouis E. SilvermanIndependent Director
- DRDavid R. GandaraMember of Scientific & Medical Advisory Board
